市場調査レポート

商品コード

1608845

大腸がん治療薬市場：治療タイプ別、投与経路別、流通チャネル別、地域別

Colorectal Cancer Therapeutics Market, By Therapy Type (Chemotherapy, Immunotherapy, Targeted Therapy, and Others), By Route of Administration, By Distribution Channel, By Geography

出版日: 2024年11月04日
発行: Coherent Market Insights
ページ情報: 英文 167 Pages
納期: 2～3営業日

カスタマイズ可能

価格

PDF (Single User License)

USD 4,500 648,270円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は一度のみ可能です。印刷したもののご利用はPDFのライセンス保持者に限定されます。

PDF (Multi User License)

USD 7,000 1,008,420円

レポートPDFを7名までにてご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は7回まで可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise User License)

USD 10,000 1,440,600円

レポートPDFを同一企業およびその子会社のすべての方に使用頂けるライセンスです。PDF内のテキスト等のコピーは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=144.06円

全表示
概要
目次

概要

サンプル依頼リストに入れる

大腸がん治療薬市場は、2024年には89億8,000万米ドルと推定され、2024年から2031年にかけてCAGR4.3％を示し、2031年には121億米ドルに達すると予測されます。

レポート範囲		レポート詳細
基準年	2023年	2024年の市場規模	89億8,000万米ドル
実績データ	2019年～2023年	予測期間	2024年から2031年
予測期間2024年から2031年 CAGR：	4.30%	2031年の金額予測	121億米ドル

図.大腸がん治療薬市場シェア（%）、地域別、2024年

Colorectal Cancer Therapeutics Market-IMG1

大腸がんは、世界で最も一般的ながんのひとつであり、がんに関連した死亡の主な原因となっています。世界保健機関（WHO）によると、2020年には世界で190万人以上が新たに大腸がんと診断され、大腸がんによる死亡者は年間90万人を超えます。大腸がんの有病率の上昇と限られた治療選択肢により、効果的な治療薬への需要が高まっています。いくつかのバイオ医薬品企業は、大腸がんを治療するために、標的モノクローナル抗体、プロテインキナーゼ阻害剤、免疫チェックポイント阻害剤などの新規標的治療アプローチの開発に注力しています。

市場力学

世界の大腸がん治療薬市場の成長は、世界の大腸がん有病率の上昇に牽引されています。米国がん協会によると、2020年には米国で毎年15万人以上の大腸がん患者が新たに診断されるといいます。さらに、大腸がんの早期発見と治療に関する認識を広めるための政府やがん団体によるイニシアチブの増加は、市場の成長を促進する可能性があります。しかし、新規の標的療法に関連する高額な費用は、その普及を妨げる可能性があります。新世代のバイオマーカー誘導個別化療法を開発するための継続的な研究開発は、有利な成長機会を生み出す可能性があります。

本調査の主な特徴

本レポートでは、世界の大腸がん治療薬市場を詳細に分析し、2023年を基準年とした予測期間（2024-2031年）の市場規模および年間平均成長率（CAGR%）を掲載しています。

また、さまざまなセグメントにわたる潜在的な収益機会を明らかにし、この市場の魅力的な投資提案マトリクスについて解説しています。

また市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する重要な考察も提供しています。

世界の大腸がん治療薬市場における主要企業を、企業ハイライト、製品ポートフォリオ、主要ハイライト、業績、戦略などのパラメータに基づいてプロファイルしています。

本調査の対象となる主要企業には、Sanofi社、Bristol-Myers Squibb Company社、Bayer AG社、Ono Pharmaceutical Co.Ltd.、ALX Oncology Inc.、第一三共株式会社、Pfizer Inc.、Exelixis, Inc.、SOTIO Biotech AG、AB Science、BioNTech SE、Effector Therapeutics, Inc.、Treos Bio Limitedなどです。

本レポートからの洞察により、マーケティング担当者や企業の経営陣は、将来の製品上市、タイプアップ、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことができます。

世界の大腸がん治療薬市場レポートは、投資家、サプライヤー、製品メーカー、販売業者、新規参入者、財務アナリストなど、この業界の様々な利害関係者に対応しています。

利害関係者は、世界の大腸がん治療薬市場の分析に使用される様々な戦略マトリックスを通じて、意思決定が容易になります。

Report Coverage	Report Details
Base Year:	2023	Market Size in 2024:	8.98 Bn
Historical Data for:	2019 to 2023	Forecast Period:	2024 to 2031
Forecast Period 2024 to 2031 CAGR:	4.30%	2031 Value Projection:	12.10 Bn

Colorectal cancer is one of the most common cancers worldwide and a leading cause of cancer-related mortality. According to World Health Organization (WHO), in 2020, over 1.9 million new cases of colorectal cancer are diagnosed globally and more than 0.9 million deaths due to colorectal cancer occur annually. Rising prevalence of colorectal cancer and limited treatment options have boosted demand for effective therapeutics. Several biopharma companies are focusing on developing novel targeted therapeutic approaches such as targeted monoclonal antibodies, protein kinase inhibitors, and immune checkpoint inhibitors to treat colorectal cancer.

Market Dynamics

Global colorectal cancer therapeutics market growth is driven by rising prevalence of colorectal cancer worldwide. In 2020, according to the American Cancer Society, over 150,000 new cases of colorectal cancer are diagnosed in the U.S. every year. Moreover, increasing initiatives by governments and cancer organizations to spread awareness about early detection and treatment of colorectal cancer can drive the market growth. However, high costs associated with novel targeted therapies can hamper its widespread adoption. Ongoing research & development for developing new generation biomarker-guided personalized therapies can create lucrative growth opportunities.

Key features of the study

This report provides in-depth analysis of the global colorectal cancer therapeutics market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global colorectal cancer therapeutics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Sanofi, Bristol-Myers Squibb Company, Bayer AG, Ono Pharmaceutical Co. Ltd, ALX Oncology Inc., Daiichi Sankyo Company, Limited, Pfizer Inc., Exelixis, Inc., SOTIO Biotech AG, AB Science, BioNTech SE, Effector Therapeutics, Inc., and Treos Bio Limited

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global colorectal cancer therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global colorectal cancer therapeutics market

Market Segmentation

Therapy Type Insights (Revenue, USD, 2019 - 2031)
- Chemotherapy
- Alkylating Agents
- Antimetabolites
- Others
- Immunotherapy
- Immune Checkpoint Inhibitors
- Oncolytic Virus Therapy
- Others
- Targeted Therapy
- Monoclonal antibodies
- Small molecule inhibitors
- Others
Route of Administration Insights (Revenue, USD, 2019 - 2031)
- Oral
- Intravenous
- Intramuscular
- Subcutaneous
- Others
Distribution Channel Insights
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Regional Insights (Revenue, USD, 2019 - 2031)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Sanofi
- Bristol-Myers Squibb Company
- Bayer AG
- Ono Pharmaceutical Co. Ltd
- ALX Oncology Inc.
- Daiichi Sankyo Company, Limited
- Pfizer Inc.
- Exelixis, Inc.
- SOTIO Biotech AG
- AB Science
- BioNTech SE
- Effector Therapeutics, Inc.
- Treos Bio Limited

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Colorectal Cancer Therapeutics Market, By Therapy Type
- Colorectal Cancer Therapeutics Market, By Route of Administration
- Colorectal Cancer Therapeutics Market, By Distribution Channel
- Colorectal Cancer Therapeutics Market, Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Epidemiology
Pipeline Analysis

4. Colorectal Cancer Therapeutics Market, By Therapy Type, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Chemotherapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Alkylating Agents
- Antimetabolites
- Others
Immunotherapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Immune Checkpoint Inhibitors
- Oncolytic Virus Therapy
- Others
Targeted Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Monoclonal antibodies
- Small molecule inhibitors
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

5. Colorectal Cancer Therapeutics Market, By Route of Administration, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Intravenous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Intramuscular
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Subcutaneous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Colorectal Cancer Therapeutics Market, By Distribution Channel, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Colorectal Cancer Therapeutics Market, By Region, 2019 - 2031, (USD Bn)

Introduction
- Market Share (%) Analysis, 2024,2027 & 2031, (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2020 - 2031, (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Therapy Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Therapy Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Therapy Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Therapy Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Therapy Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Therapy Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country/Region, 2019 - 2031, (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

8. Competitive Landscape

Sanofi
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bristol-Myers Squibb Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bayer AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Ono Pharmaceutical Co. Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
ALX Oncology Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Daiichi Sankyo Company, Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Exelixis, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
SOTIO Biotech AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
AB Science
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
BioNTech SE
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Effector Therapeutics, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Treos Bio Limited

9. Analyst Recommendations

Wheel of Fortune
Analyst View
Coherent Opportunity Map

10. References and Research Methodology

References
Research Methodology
About us

大腸がん治療薬市場：治療タイプ別、投与経路別、流通チャネル別、地域別

Colorectal Cancer Therapeutics Market, By Therapy Type (Chemotherapy, Immunotherapy, Targeted Therapy, and Others), By Route of Administration, By Distribution Channel, By Geography

市場力学

目次

第1章調査の目的と前提条件

第2章市場の展望

第3章市場力学、規制、動向分析

第4章大腸がん治療薬市場、治療タイプ別、2019年-2031年

第5章大腸がん治療薬市場、投与経路別、2019年-2031年

第6章大腸がん治療薬市場、流通チャネル別、2019年～2031年

第7章大腸がん治療薬市場、地域別、2019年-2031年

第8章競合情勢

第9章アナリストの推奨事項

第10章参考文献と調査手法

Market Dynamics

Market Segmentation

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Colorectal Cancer Therapeutics Market, By Therapy Type, 2019-2031, (USD Bn)

5. Colorectal Cancer Therapeutics Market, By Route of Administration, 2019-2031, (USD Bn)

6. Colorectal Cancer Therapeutics Market, By Distribution Channel, 2019-2031, (USD Bn)

7. Colorectal Cancer Therapeutics Market, By Region, 2019 - 2031, (USD Bn)

8. Competitive Landscape

9. Analyst Recommendations

10. References and Research Methodology

大腸がん治療薬市場：治療タイプ別、投与経路別、流通チャネル別、地域別

Colorectal Cancer Therapeutics Market, By Therapy Type (Chemotherapy, Immunotherapy, Targeted Therapy, and Others), By Route of Administration, By Distribution Channel, By Geography

市場力学

目次

第1章 調査の目的と前提条件

第2章 市場の展望

第3章 市場力学、規制、動向分析

第4章 大腸がん治療薬市場、治療タイプ別、2019年-2031年

第5章 大腸がん治療薬市場、投与経路別、2019年-2031年

第6章 大腸がん治療薬市場、流通チャネル別、2019年～2031年

第7章 大腸がん治療薬市場、地域別、2019年-2031年

第8章 競合情勢

第9章 アナリストの推奨事項

第10章 参考文献と調査手法

Market Dynamics

Market Segmentation

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Colorectal Cancer Therapeutics Market, By Therapy Type, 2019-2031, (USD Bn)

5. Colorectal Cancer Therapeutics Market, By Route of Administration, 2019-2031, (USD Bn)

6. Colorectal Cancer Therapeutics Market, By Distribution Channel, 2019-2031, (USD Bn)

7. Colorectal Cancer Therapeutics Market, By Region, 2019 - 2031, (USD Bn)

8. Competitive Landscape

9. Analyst Recommendations

10. References and Research Methodology

第1章調査の目的と前提条件

第2章市場の展望

第3章市場力学、規制、動向分析

第4章大腸がん治療薬市場、治療タイプ別、2019年-2031年

第5章大腸がん治療薬市場、投与経路別、2019年-2031年

第6章大腸がん治療薬市場、流通チャネル別、2019年～2031年

第7章大腸がん治療薬市場、地域別、2019年-2031年

第8章競合情勢

第9章アナリストの推奨事項

第10章参考文献と調査手法